← Signals · Consumer Staples · TSXV
$EBM
Eastwood Bio-Medical Canada Inc.
Signal as of October 14, 2026  ·  90-day rolling window  ·  Consumer Products - Healthcare
Confluence Score
50
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 40–59 have historically hit 41% of the time (avg +7.1% over 90 days, 4424 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
Confluence Score
50
Insider Activity (90d)
2
2 buyers  ·  $10K  ·  open-market only
Current Price
$1.69
CAD  ·  5-min cache
Market Cap
$116M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:EBM
Insider Transactions
90-day window  ·  2 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Sep 08, 2026 Kim, Yunji — Open Market Buy 500 $1.89 -10.6%  · 43d $945
Sep 08, 2026 Eastwood Bio-Medical Research Inc. — Open Market Buy 5,000 $1.87 -9.6%  · 43d $9K
Score uses open-market buys only  ·  2 open-market  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 25 30 2 unique buyers
Buy/sell ratio 20 100% buys (2B / 0S)
Dollar value 25 $10K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 50 100
Unlock Component Detail — CAD $29/mo
Buying Insiders
Open-market · 90 days · 2 unique buyers
Insider Credibility Hit Rate Avg 90d Return Trades (eval'd) Buy Value (90d) Last Buy
Eastwood Bio-Medical Research Inc. — — — — $9K Sep 08, 2026
Kim, Yunji — — — — $945 Sep 08, 2026
Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for EBM.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Sep 30, 2026
Shares short
1,007
Net change
-2,908 (-74.3%)
History
Sep 30: 1,007
Sep 15: 3,915
Aug 31: 2,790
Aug 15: 1,065
Jul 31: 6,249
Jul 15: 732
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.